KLP Kapitalforvaltning AS Takes $4.23 Million Position in DaVita Inc. (NYSE:DVA)

KLP Kapitalforvaltning AS acquired a new stake in DaVita Inc. (NYSE:DVA) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 28,314 shares of the company’s stock, valued at approximately $4,234,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. SBI Securities Co. Ltd. bought a new position in shares of DaVita during the 4th quarter worth $41,000. Quarry LP bought a new position in DaVita during the third quarter worth about $60,000. Venturi Wealth Management LLC increased its stake in shares of DaVita by 59.8% in the fourth quarter. Venturi Wealth Management LLC now owns 406 shares of the company’s stock worth $61,000 after purchasing an additional 152 shares in the last quarter. Versant Capital Management Inc raised its position in shares of DaVita by 58.7% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $68,000 after purchasing an additional 169 shares during the period. Finally, Blue Trust Inc. boosted its holdings in DaVita by 39.7% in the 4th quarter. Blue Trust Inc. now owns 461 shares of the company’s stock worth $76,000 after buying an additional 131 shares during the period. 90.12% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on DVA. Barclays boosted their target price on shares of DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a report on Tuesday, February 18th. StockNews.com cut DaVita from a “buy” rating to a “hold” rating in a report on Friday, March 21st. Cowen reaffirmed a “hold” rating on shares of DaVita in a report on Tuesday, February 18th. Finally, Sanford C. Bernstein set a $184.00 price target on shares of DaVita in a report on Friday, February 21st. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has given a buy rating to the company. According to data from MarketBeat.com, DaVita presently has an average rating of “Hold” and a consensus target price of $166.33.

DaVita Stock Up 0.3 %

DVA stock opened at $151.30 on Thursday. DaVita Inc. has a 1-year low of $125.64 and a 1-year high of $179.60. The stock has a market cap of $12.10 billion, a price-to-earnings ratio of 14.09, a price-to-earnings-growth ratio of 1.07 and a beta of 0.99. The company has a current ratio of 1.26, a quick ratio of 1.21 and a debt-to-equity ratio of 23.18. The company’s 50 day moving average is $157.96 and its 200 day moving average is $157.53.

DaVita (NYSE:DVA) last announced its earnings results on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. Sell-side analysts predict that DaVita Inc. will post 10.76 EPS for the current fiscal year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.